Veradigm | MDRX - Ebitda





Ebitda Veränderung Datum
Alcidion AUD 4.19M 365K 2025-12
Ambu A/S DKK 271M 10M 2026-03
Amplifon EUR 141.76M 19.85M 2026-03
Cardinal Health USD 1.09B 109M 2026-03
Centene USD 1.55B 1.01B 2026-06
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cigna USD 2.86B 56M 2025-03
Coloplast 2.39B 132M 2025-09
Convatec Group USD 286.8M 27.5M 2024-12
CVS Health USD 5.83B 2.08B 2026-03
Diasorin EUR 90M 2M 2026-03
Elevance Health USD 4.21B 2.02B 2026-03
General Electric Aerospace USD 3.06B 219M 2026-06
Gulf Medical Proj AED 35.5M 2.9M 2025-03
Humana USD 2.06B 2.35B 2026-03
IQVIA Holdings USD 994M 62M 2026-06
Laboratory Of America USD 605.6M 17.5M 2026-03
Maximus USD 188.03M 17.61M 2026-03
McKesson USD 1.88B 206M 2025-12
Med Life RON 108.31M 30.25M 2025-09
Molina Healthcare USD 197M 70M 2026-06
Omnicell USD 44.65M 22.46M 2026-03
Oriola-kd EUR 7.7M 2.2M 2026-03
Owens Minor USD 90.02M 2.15M 2025-12
Quest Diagnostics USD 648M 91M 2026-06
Rede D'or Sao Luiz BRL 3.59B 505.3M 2026-03
Siemens Healthineers EUR 1.11B 83M 2025-12
Supermax Corporation Bhd MYR -37.85M 103.53M 2026-03
UnitedHealth USD 9.43B 567M 2026-06
Veeva Systems USD 403.96M 29.17M 2026-03
Veradigm USD 38.81M 29.61M 2022-09
Xerox USD 110M 54M 2025-06